TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06547775

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN069
Description: Solution for SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN069
Description: Solution for SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN069
Description: Solution for SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN069
Description: Solution for SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN069
Description: Solution for SC injection
Study: NCT06490133

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Polyhpenol extract
Description: Three capsules in fasting conditions 15 minutes prior breakfast

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Three capsules in fasting conditions 15 minutes before breakfast
Study: NCT06190249

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LN-144
Description: A tumor sample is resected from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, patient is infused with autologous TIL (LN-144), followed by IL-2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesna
Description: Given by IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given by IV.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2)
Description: Given by IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given by IV.
Study: NCT05924945

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bridge™ active device
Description: Bridge is a percutaneous nerve field stimulation device

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Bridge™ sham device
Description: The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses.
Study: NCT06064071

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nordlys SWT IPL
Description: Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Meibomian Gland Expression (MGX)
Description: Meibomian glands are squeezed (by applying force on the inner and outer surfaces of the eyelid with a specially designed forceps, Q-tips, or fingers) in order to unclog obstructed glands and evacuate their content (the meibum), which in MGD is often viscous and thus causing obstruction

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Meibomian Gland Expression (MGX)
Description: Meibomian glands are squeezed (by applying force on the inner and outer surfaces of the eyelid with a specially designed forceps, Q-tips, or fingers) in order to unclog obstructed glands and evacuate their content (the meibum), which in MGD is often viscous and thus causing obstruction
Study: NCT05595915

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: COMP-4
Description: COMP-4 is a novel compound that consists of ginger extract, L-citrulline, and the herbal components Paullinia cupana and muira puama.
Study: NCT05583903

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Software
Description: The ReCognition virtual reality software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Software
Description: The ReCognition virtual reality software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions.
Study: NCT05952648

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lower tract respiratory samples
Description: Within 1 hour from HAP or VAP suspicion, quantitative tracheal aspirate or bronchoalveolar lavage will be performed to confirm the diagnosis. Clinicians will be encouraged to perform BAL whenever possible

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lower tract respiratory samples
Description: Within 1 hour from HAP or VAP suspicion, quantitative tracheal aspirate or bronchoalveolar lavage will be performed to confirm the diagnosis. Clinicians will be encouraged to perform BAL whenever possible

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multiplex PCR assay (Film-array Pneumonia Panel Plus)
Description: The lower tract respiratory samples will be analyzed with Multiplex PCR assay (Film-array Pneumonia Plus).
Study: NCT05368376

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Labetalol Hydrochloride Oral Tablet
Description: Labetalol 200 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoprolol Tartrate Oral Tablet
Description: Metoprolol 100 mg
Study: NCT04993937

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Interventional group will receive 6 weeks of plyometric training and receive training for week and three sessions in a week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Control group will follow their daily routine activities and may involve in any other exercise program rather than plyometric exercises.
Study: NCT04865536

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1800 mg TBI-223
Description: 3 x 600 mg SR1 tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1800 mg TBI-223
Description: 3 x 600 mg SR1 tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2400mg TBI-223
Description: 3 x 600 mg SR1 tablets and 1 x 600 mg IR tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2400mg TBI-223
Description: 3 x 600 mg SR1 tablets and 1 x 600 mg IR tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3000mg TBI-223
Description: 4 x 600 mg SR1 tablets and 1 x 600 mg IR tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TBI-223 Placebo
Description: 3 x Placebo tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TBI-223 Placebo
Description: 3 x Placebo tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TBI-223 Placebo
Description: 4 x Placebo tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TBI-223 Placebo
Description: 4 x Placebo tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TBI-223 Placebo
Description: 5 x Placebo tablets
Study: NCT05347173

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: patients who will receive 2.5 mL hyperbaric bupivacaine (0.5%) plus Dexmedetomidine (10 µg in 0.5 mL normal saline)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nalbuphine
Description: patients who will receive 2.5 mL hyperbaric bupivacaine (0.5%) plus Nalbuphine (1 mg in 0.5 mL normal saline)
Study: NCT06540690

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Palatal Wound
Description: With the goal to harvest the free gingival graft (FGG), an 8mm diameter scalpel will be used to ensure standardized wounds. Thereafter, a 2-mm thick FGG will be removed. The wound area will receive 4.0 silk sutures.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Palatal Wound
Description: With the goal to harvest the free gingival graft (FGG), an 8mm diameter scalpel will be used to ensure standardized wounds. Thereafter, a 2-mm thick FGG will be removed. The wound area will receive 4.0 silk sutures.
Study: NCT04753931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory Training in addition to Bobath Training
Description: Trunk-focused exercises will be applied for different senses (tactile, proprioceptive, etc.) in addition to Bobath exercises. Bobath exercises will be determined individually according to the evaluation results. In general, exercises aiming to muscle tone regulation, increase balance, walking, and functionality will be applied. Trunk-focused Bobath exercises will be selected.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bobath Training
Description: Bobath exercises will be determined individually according to the evaluation results. In general, exercises aiming to muscle tone regulation, increase balance, walking, and functionality will be applied. Trunk-focused Bobath exercises will be selected.
Study: NCT06542393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythropoietin
Description: * Treatment regimen for hospitalized patients awaiting non-urgent surgeries: Administer EPO 600 IU/kg/week via subcutaneous (SC) or intravenous (IV) route, followed by 300 IU/kg/day via SC or IV 10 days before surgery. If ferritin \< 100 ng/dL, supplement with IV iron (Iron hydroxide up to 600 mg/week or Ferric carboxymaltose up to 1000 mg/week).~* Treatment regimen for hospitalized patients awaiting non-urgent surgeries with less than 5 days until surgery: Administer 40000 UI of EPO intravenous (IV) attack and supplement with IV iron (Iron hydroxide up to 600 mg/week or Ferric carboxymaltose up to 2000 mg/week), then 300UI/Kg/day IV or SC of EPO until day of surgery.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blood transfusion
Description: After surgery, this group will receive one unit of RBC at the moment of ICU admission.~Hb \> 8 g/dl: 1 unit of RBC. HB \< 8 g/dl: 2 units of RBC.
Study: NCT06032260

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enriched panettone
Description: Volunteers consumed 100 grams of panettone enriched with fiber (JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Panettone standard
Description: Volunteers consumed 100 grams of panettone standard
Study: NCT05864209

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phthalate- and Bisphenol-free Baby Products
Description: 3-month supply. Products include wipes and diaper cream.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cloth Diapers
Description: Subscription to cloth diaper service.
Study: NCT05952648

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lower respiratory tract standard culture
Description: The lower tract respiratory samples will be analyzed using convention microbiological methods (including conventional Gram stain and semiquantitative culture on both selective/differential and screening agar media)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Lower respiratory tract standard culture
Description: The lower tract respiratory samples will be analyzed using convention microbiological methods (including conventional Gram stain and semiquantitative culture on both selective/differential and screening agar media)

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood sample standard culture
Description: When HAP or VAP are suspected, blood samples from peripheral vein will be collected and analyzed with conventional microbiological methods

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood sample standard culture
Description: When HAP or VAP are suspected, blood samples from peripheral vein will be collected and analyzed with conventional microbiological methods
Study: NCT05864209

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Disposable Diapers
Description: 3-month supply.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Baby Products
Description: Products include wipes and diaper cream.
Study: NCT05645822

Intervention type: OTHER
Intervention: Screen&treat
Description: Study participants will be tested with an RDT to prove the presence of antibodies against Trypanosoma brucei gambiense. Should the RDT be positive, they will be offered the 10-day treatment with fexinidazole, and an additional blood sample will be taken for the post hoc confirmation of the disease.
Study: NCT06723990

Intervention type: DRUG
Intervention: Neoadjuvant standard treatment for HER2+
Description: NEOADJUVANT SETTING

Intervention type: DRUG
Intervention: Adjuvant standard treatment for HER2+
Description: ADJUVANT SETTING
Study: NCT06724666

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transdiagnostic Internet-delivered intervention
Description: The intervention consists of 8 modules based on Rational emotive therapy, delivered via 8 weeks.
Study: NCT06724328

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gentle Human Touch
Description: the trained NICU nurse will place one hand's fingertips on the baby's forehead along the brow line, while the other hand will be placed around the baby's lower abdomen

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Maternal Heartbeat and Gentle Human Touch
Description: maternal heartbeat will be played and GHT steps will be applied simultaneously at the designated times
Study: NCT06638892

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Using PrEP, Doing it for Ourselves (UPDOs)
Description: An e-Health intervention that considers women's lived experiences and uses three components: beauty salons and stylists as opinion leaders (trusted gatekeepers who share health information in the community), theory driven edutainment videos and blogs, and a secure online platform for accessing pre-exposure prophylaxis (PrEP).

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: CDC standard of care, e.g., CDC videos and website.
Study: NCT05472142

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UP FOR IT - practice facilitation
Description: Using Practice Facilitation and Operationalizing Referral Information Technology (UP FOR IT) involves incorporation of health information technology and practice facilitation. The practice facilitation collaborative trains and supports clinical teams to use the Model for Improvement to make breakthrough improvements in diabetes care and DSMES utilization by recognizing barriers and changing clinical systems and care practices.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: UP FOR IT - health information technology
Description: Using Practice Facilitation and Operationalizing Referral Information Technology (UP FOR IT) involves incorporation of health information technology and practice facilitation. The health information technology component provides the scaffolding for quality improvement efforts by automating patient identification and enabling bi-directional referral communication between providers and diabetes self-management education and services (DSMES) programs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UP FOR IT - health information technology
Description: Using Practice Facilitation and Operationalizing Referral Information Technology (UP FOR IT) involves incorporation of health information technology and practice facilitation. The health information technology component provides the scaffolding for quality improvement efforts by automating patient identification and enabling bi-directional referral communication between providers and diabetes self-management education and services (DSMES) programs.
Study: NCT06511076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zilucoplan
Description: Participants will receive a single sc injection of zilucoplan in the pre-specified sequence.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zilucoplan
Description: Participants will receive a single sc injection of zilucoplan in the pre-specified sequence.
Study: NCT06343662

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MERAKI_ABI
Description: The music therapy session will focus on the themes of reidentification and involvement. The aim is to accompany the patient during the illness process, allowing them to express their emotional state, relate to music, promote listening and communication between family members, help and value preserved abilities, and promote personal involvement in the rehabilitation process.~The session will work with songs, taking into account musical preferences.
Study: NCT06724328

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Maternal Heartbeat
Description: The recording of the mother's heartbeat will be done when the mother's mood is stable and the environment is quiet. A Doppler fetal heart monitor will be used to detect the mother's heartbeat. After ensuring a regular and stable heart rate, the mother's heartbeat will be recorded for 15 minutes using a recording device
Study: NCT05903092

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: 1500mg IV on Day 1 of every Cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monalizumab
Description: 1500mg IV on Day 1 of every Cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin or Cisplatin
Description: On Day 1 of Cycles 1-4 by IV:~Carboplatin: AUC 5-6 OR Cisplatin: 75-80mg/m\^2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: 80-100mg/m\^2 IV on Days 1-3 of Cycles 1-4
Study: NCT05065151

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stimulation on
Description: Stimulation from Percept PC DBS will be on while the patient is playing a decision-making game on a computer-based application.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stimulation off
Description: Stimulation from Percept PC DBS will be off while the patient is playing a decision-making game on a computer-based application.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decision Making Task
Description: Patients will be playing a decision making task through a computer-based application.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decision Making Task
Description: Patients will be playing a decision making task through a computer-based application.
Study: NCT06528301

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: UB-VV111
Description: UB-VV111 is a gene therapy that generates CD19 CAR T cells in the body.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: UB-VV111
Description: UB-VV111 is a gene therapy that generates CD19 CAR T cells in the body.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rapamycin
Description: Rapamycin is an FDA-approved drug.
Study: NCT05156060

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Taken by mouth 3 times per day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Administered intranasally 3 times per day
Study: NCT06132087

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood and tissue sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Distal Pancreatectomy
Description: Undergo distal pancreatectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Description: Undergo laparoscopy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pancreaticoduodenectomy
Description: Undergo pancreaticoduodenectomy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Procedure
Description: Undergo surgical resection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total Pancreatectomy
Description: Undergo total pancreatectomy
Study: NCT06064071

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Nordlys SWT IPL
Description: Sham treatment with Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators device turned off
Study: NCT05906836

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Administered orally.
Study: NCT05370131

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Avatar-Based Education Program in Hydrocephalus (ABEP-H)
Description: The avatar-based education program in hydrocephalus (ABEP-H) aimed to help parents acquire the knowledge and develop the skills necessary for the care of hydrocephalus children with VP shunts and prevent shunt infection and dysfunction.
Study: NCT05782062

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cleaner XT
Description: Wire like device that rotates to allow for wall to wall disruption of thrombus.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Balloon
Description: Use of balloon for disrupting thrombus.
Study: NCT05034419

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Parasym
Description: Stimulation will be done under anesthesia for 30 minutes. Stimulation parameters include a pulse width of 200 μs, amplitude of 20 mA and a pulse frequency of 20 Hz. The Parasym devise (Parasym Health, London, UK) will be used for stimulation. The device will be connected to a clip electrode that will be attached to the external ear. In the active group, the ear clip electrode will be attached to tragus in the active stimulation group. This device has been deemed non-significant risk by the FDA. In the control group, no stimulation will be done.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: Sham stimulation
Study: NCT05993663

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arts in health group intervention
Description: 12 sessions using the Arts in Health methodology with the aim of having a better understanding of the disease, developing healthy lifestyle habits and greater emotional intelligence. Visual thinking strategies, game based activities, mindfulness and dance will be used
Study: NCT06551467

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Ayurveda Program for Detox and Lifestyle
Description: The program includes personalized herbal remedies, detoxification procedures, dietary guidelines, yoga exercises, and daily routine practices.